Company attributes
Other attributes
Common Sensing is a company that develops and manufactures hardware and software solutions for people who require the use of injectable medicine. The company was founded by James White and Richard Whalley in 2012, in Cambridge, Massachusetts, United States.
Common Sensing has developed smart injector pens that connect to a cloud platform and work for data regarding insulin, GLP-1, fertility hormones, and human growth hormones in order to make treatments more available for clinicians and patients.
The company's product is the Gocap System which is a smart cap that automatically sends drug-delivery data from the disposable pen-injector to a mobile application. The product provides patient information for healthcare providers and is blue-tooth enabled. Their product tracks dose logging, temperature monitoring, provides reminders and alerts, as well as customization within their application platform.
The company has participated in funding rounds and has received investments from Haselmeier, Waterline Ventures, Royal Philips, Qualcomm Ventures, and New World Health.
